Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Ouyang

Showing results (81-90 of 360) with videos related to

Pageof 36
Sort By:
Translational Andrology and Urology|January 18, 2021
Expression and clinical significance of interleukin-9 in renal tumorsZhiyu Zhang, Qi Zhou, Jun Ouyang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 22, 2022
NEDD4L represses prostate cancer cell proliferation via modulating PHF8 through the ubiquitin-proteasome pathwayRui Feng, Zhongxing Li, Guangcheng Ge, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|September 25, 2025
Potential Application Value of FASN in the Diagnosis of Colorectal CancerNan Li, Mingyue Hu, Qiliu Qian, et al.
Medicine|June 23, 2025
Construction of an immune-related prognostic model and functional analysis of CEBPB in uveal melanoma: A STROBE-compliant observational studyYulin Tao, Yirui Peng, Haibo Zhu, et al.
World Journal of Clinical Cases|December 27, 2024
Correction to: Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohortsZhen Song, Qi Zhou, Jiang-Lei Zhang, et al.
World Journal of Clinical Cases|January 31, 2024
Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohortsZhen Song, Qi Zhou, Jiang-Lei Zhang, et al.
Frontiers in Oncology|September 25, 2024
CD276 as a promising diagnostic and prognostic biomarker for bladder cancer through bioinformatics and clinical researchQi Zhou, Jianhao Xu, Xuelei Chen, et al.
International Urology and Nephrology|February 20, 2010
Comparative analysis of upper ureteral stones (> 15 mm) treated with retroperitoneoscopic ureterolithotomy and ureteroscopic pneumatic lithotripsyYunYan Wang, JianQuan Hou, DuanGai Wen, et al.
Scientific Reports|March 31, 2016
Hydrogenations and electric field induced magnetic behaviors in armchair silicene nanoribbonsDan Zhang, Mengqiu Long, Fang Xie, et al.
Frontiers in Immunology|November 18, 2024
Efficacy and safety analysis of neoadjuvant chemotherapy combined with immunotherapy in patients with muscle-invasive bladder cancerYanhang Yu, Chuanao Zhang, Hao Chen, et al.
Pageof 36

Showing results (81-90 of 360) with videos related to

Sort By:
Pageof 36
Translational Andrology and Urology|January 18, 2021
Expression and clinical significance of interleukin-9 in renal tumorsZhiyu Zhang, Qi Zhou, Jun Ouyang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 22, 2022
NEDD4L represses prostate cancer cell proliferation via modulating PHF8 through the ubiquitin-proteasome pathwayRui Feng, Zhongxing Li, Guangcheng Ge, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|September 25, 2025
Potential Application Value of FASN in the Diagnosis of Colorectal CancerNan Li, Mingyue Hu, Qiliu Qian, et al.
Medicine|June 23, 2025
Construction of an immune-related prognostic model and functional analysis of CEBPB in uveal melanoma: A STROBE-compliant observational studyYulin Tao, Yirui Peng, Haibo Zhu, et al.
World Journal of Clinical Cases|December 27, 2024
Correction to: Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohortsZhen Song, Qi Zhou, Jiang-Lei Zhang, et al.
World Journal of Clinical Cases|January 31, 2024
Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohortsZhen Song, Qi Zhou, Jiang-Lei Zhang, et al.
Frontiers in Oncology|September 25, 2024
CD276 as a promising diagnostic and prognostic biomarker for bladder cancer through bioinformatics and clinical researchQi Zhou, Jianhao Xu, Xuelei Chen, et al.
International Urology and Nephrology|February 20, 2010
Comparative analysis of upper ureteral stones (> 15 mm) treated with retroperitoneoscopic ureterolithotomy and ureteroscopic pneumatic lithotripsyYunYan Wang, JianQuan Hou, DuanGai Wen, et al.
Scientific Reports|March 31, 2016
Hydrogenations and electric field induced magnetic behaviors in armchair silicene nanoribbonsDan Zhang, Mengqiu Long, Fang Xie, et al.
Frontiers in Immunology|November 18, 2024
Efficacy and safety analysis of neoadjuvant chemotherapy combined with immunotherapy in patients with muscle-invasive bladder cancerYanhang Yu, Chuanao Zhang, Hao Chen, et al.
Pageof 36